2023 PCE Oncology Spring Conferences – Hematologic Malignancies

PCE, the national leader in continuing education for NPs and PAs, presents the 2023 PCE Oncology Spring Conferences – Hematologic Malignancies. This complimentary CE/CME meeting is tailored to meet the clinical needs and evolving scope of practice of NPs, PAs, and nurses who practice in oncology. Review the latest evidence-based strategies for contemporary care of your patients with hematologic malignancies with downloadable slides from CCO and PCE. 

Share

Provided by

ProCE Banner
ProCE Banner

Supporters

Supported by educational grants from AstraZeneca; Bristol-Myers Squibb; CTI BioPharma Corp; GSK; and Incyte Corporation.

AstraZeneca

Bristol Myers Squibb

CTI BioPharma Corp., a Sobi Company

GSK

Incyte Corporation